New salvage treatment for AML/MDS after allogeneic transplant: the VIOLA trial
The outcome for patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) after allogeneic stem cell transplantation remains poor. In this interview, Charles Craddock, CBE, FRCP (U...
Author: VJHemOnc
Added: 12/18/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Leukemia | Myelodysplastic Syndrome | Stem Cell Therapy | Stem Cells | Transplants